Azora Therapeutics (AZR) vs XBiotech (XBIT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Azora Therapeutics is the larger company by market cap ($55.0 million vs $52.7 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AZR | XBIT |
|---|---|---|
| Share price | $3.85 | $1.73 |
| Market cap | $55.00M | $52.74M |
| 1-day change | -0.52% | +2.98% |
| YTD return | — | -27.62% |
| 1-year return | — | -24.12% |
| 5-year return | — | -86.48% |
| Forward P/E | — | 13.31 |
| EPS (TTM) | $-18.09 | $-1.43 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Net income (latest FY) | $-7.98M | $-45.54M |
| 52-week high | $8.25 | $2.73 |
| 52-week low | $1.31 | $1.61 |
| Distance from 52-week high | -53.33% | -36.63% |
| Average volume | 50.12K | 64.77K |
| Shares outstanding | 14.29M | 30.49M |
| Employees | — | 87 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About XBiotech
XBIT stock →XBiotech Inc., a biopharmaceutical company, discovers, and develops, True Human monoclonal antibodies for treating various diseases. It develops a pipeline of product candidates targeting inflammatory and infectious diseases.
Health Care · Biotechnology: Pharmaceutical Preparations · 87 employees
AZR vs XBIT FAQ
Which is bigger, Azora Therapeutics or XBiotech?
Azora Therapeutics (AZR) is larger, with a market capitalization of $55.00M compared with $52.74M for XBiotech (XBIT).
Are Azora Therapeutics and XBiotech in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.